| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
30,102 |
16,171 |
$625K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,828 |
4,674 |
$221K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
11,084 |
4,447 |
$124K |
| 99233 |
Prolong inpt eval add15 m |
6,955 |
1,257 |
$105K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
10,423 |
5,156 |
$104K |
| J1756 |
Injection, iron sucrose, 1 mg |
4,103 |
1,095 |
$87K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,832 |
1,369 |
$80K |
| 96367 |
|
4,796 |
1,910 |
$70K |
| 99223 |
Prolong inpt eval add15 m |
1,358 |
1,217 |
$40K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
169 |
54 |
$31K |
| 96415 |
|
2,703 |
1,293 |
$29K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,864 |
428 |
$26K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
6,916 |
2,808 |
$17K |
| 99254 |
|
317 |
220 |
$16K |
| J3490 |
Unclassified drugs |
9,223 |
3,583 |
$14K |
| 99215 |
Prolong outpt/office vis |
384 |
205 |
$13K |
| 96417 |
|
592 |
324 |
$13K |
| 99234 |
|
265 |
64 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
5,509 |
2,010 |
$11K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,169 |
445 |
$11K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
72 |
24 |
$11K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,647 |
1,158 |
$10K |
| 99222 |
Initial hospital care, per day, moderate complexity |
817 |
349 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,285 |
1,259 |
$8K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
196 |
112 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
121 |
111 |
$6K |
| J7050 |
Infusion, normal saline solution, 250 cc |
6,816 |
2,352 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
7,669 |
2,928 |
$4K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
174 |
99 |
$3K |
| 99253 |
|
41 |
40 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,654 |
1,634 |
$2K |
| 99242 |
|
162 |
67 |
$2K |
| 96401 |
|
108 |
25 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,767 |
1,718 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
3,208 |
1,713 |
$2K |
| 99245 |
|
13 |
13 |
$1K |
| J7070 |
Infusion, d5w, 1000 cc |
628 |
204 |
$1K |
| 99205 |
Prolong outpt/office vis |
12 |
12 |
$992.43 |
| 90756 |
|
68 |
68 |
$875.27 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
66 |
24 |
$805.24 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
2,650 |
869 |
$737.15 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
60 |
60 |
$682.32 |
| 96523 |
|
946 |
534 |
$566.73 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
321 |
156 |
$300.22 |
| 90656 |
|
17 |
17 |
$274.97 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
135 |
126 |
$177.83 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
49 |
27 |
$57.54 |
| 36410 |
|
144 |
57 |
$36.41 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
248 |
116 |
$25.30 |
| G0008 |
Administration of influenza virus vaccine |
12 |
12 |
$0.00 |